EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Chromatin Remodeler RSF1 as an Oncogenic Driver and Therapeutic Target in Esophageal Squamous Cell Carcinoma

Zhenhua Du, Zhili Jia, Yao Lin, Xudong Zhao iD, Gengsheng Cao, Hengbin Wang iD

Cells · 2025

DOI: 10.3390/cells14161262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Zhenhua Du und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Henan University, Kaifeng 475004, China. Hauptthemen laut MEDLINE: Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Trans-Activators, Nuclear Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Esophageal squamous cell carcinoma (ESCC) is a prevalent malignancy, ranking eleventh in incidence and seventh in mortality globally. Remodeling and Spacing factor 1 (RSF1), a chromatin remodeling factor, is frequently overexpressed in various tumors and correlates with poor prognosis. This study, combining public database analysis and clinical sample validation, reveals significantly elevated RSF1 expression in ESCC tumor tissues, confirmed further in an ESCC orthotopic model. Functional assays show that RSF1 knockout (KO) significantly inhibits ESCC cell proliferation, migration, invasion, and in vivo tumor growth, while reintroducing RSF1 restores its oncogenic effects. Proteomic analysis highlights that RSF1 KO disrupts pathways associated with cell cycle control, apoptosis, and focal adhesion. Experimentally, RSF1 KO induces apoptosis and G2/M arrest, establishing its essential role in ESCC progression. Collectively, these findings establish RSF1 as an oncogenic driver and a promising therapeutic target in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsTrans-ActivatorsNuclear ProteinsCarcinogenesisChromatin Assembly and DisassemblyOncogenesHumansCell Line, TumorAnimalsCell ProliferationGene Expression Regulation, NeoplasticApoptosisCell MovementMiceFemaleMice, NudeMaleMice, Inbred BALB C

Stichwörter der Autor:innen

RSF1apoptosiscell cycleesophageal squamous cell carcinoma

Substanzen

RSF1 protein, humanTrans-ActivatorsNuclear Proteins

Autor:innen und Institutionen

  • School of Life Sciences, Henan University, Kaifeng 475004, China.
  • Department of Obstetrics and Gynecology, Li Ka Shing Faculty of Medicine, The University ofHong Kong, Hong Kong 999077, China.
  • Department of Internal Medicine, Division of Hematology, Oncology and Palliative Care, Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.

ORCID-Profile: Xudong Zhao, Hengbin Wang

Förderung

  • Henan University

Zitieren

APA

Du, Z., Jia, Z., Lin, Y., Zhao, X., Cao, G., & Wang, H. (2025). Chromatin Remodeler RSF1 as an Oncogenic Driver and Therapeutic Target in Esophageal Squamous Cell Carcinoma. Cells. https://doi.org/10.3390/cells14161262

Vancouver

Du Z, Jia Z, Lin Y, Zhao X, Cao G, Wang H. Chromatin Remodeler RSF1 as an Oncogenic Driver and Therapeutic Target in Esophageal Squamous Cell Carcinoma. Cells. 2025. doi:10.3390/cells14161262

BibTeX
@article{Du2025,
  author = {Du, Zhenhua and Jia, Zhili and Lin, Yao and Zhao, Xudong and Cao, Gengsheng and Wang, Hengbin},
  title = {Chromatin Remodeler RSF1 as an Oncogenic Driver and Therapeutic Target in Esophageal Squamous Cell Carcinoma},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14161262}
}
Kostenlos starten →